- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 45.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 45.04M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 37.25M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.29M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $60K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$20.25M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$13.56M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $41.8M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.56M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.79M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.54M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $25.59M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $14.56M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $24.36M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.07M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.05M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $70.75M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $71.64M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $54.04M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $73.11M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $80.29M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $97.23M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.38 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.38 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.28 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.94M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.42M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $5.42M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.07M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$10.55M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$16.17M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$9.78M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $184K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.18M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.36M |